Prevalence of non-alcoholic fatty liver disease in regional Victoria: a prospective population-based study

被引:13
|
作者
Roberts, Stuart K. [1 ,2 ]
Majeed, Ammar [1 ,2 ]
Glenister, Kristen [3 ]
Magliano, Dianna [4 ]
Lubel, John S. [1 ,2 ]
Bourke, Lisa [3 ]
Simmons, David [5 ]
Kemp, William W. [1 ,2 ]
机构
[1] Alfred Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Univ Melbourne, Shepparton, Vic, Australia
[4] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[5] Western Sydney Univ, Macarthur Clin Sch, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
EXTERNAL VALIDATION; METABOLIC SYNDROME; DIAGNOSIS; MORTALITY; ENZYMES; INDEX; RISK;
D O I
10.5694/mja2.51096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate the prevalence of non-alcoholic fatty liver disease (NAFLD) and its risk factors in regional Victoria. Design: Prospective cross-sectional observational study (sub-study to CrossRoads II health study in Shepparton and Mooroopna). Setting: Four towns (populations, 6300-49 800) in the Goulburn Valley of Victoria. Participants: Randomly selected from households selected from residential address lists provided by local government organisations for participation in the CrossRoads II study. Main outcome measures: Age-and sex-adjusted estimates of NAFLD prevalence, defined by a fatty liver index score of 60 or more in people without excessive alcohol intake or viral hepatitis. Results: A total of 705 invited adults completed all required clinical, laboratory and questionnaire evaluations of alcohol use (participation rate, 37%); 392 were women (56%), and their mean age was 59.1 years (SD, 16.1 years). Of the 705 participants, 274 met the fatty liver index criterion for NAFLD (crude prevalence, 38.9%; age-and sex-standardised prevalence, 35.7%). The mean age of participants with NAFLD (61 years; SD, 15 years) was higher than for those without NAFLD (58 years; SD, 16 years); a larger proportion of people with NAFLD were men (50% v 41%). Metabolic risk factors more frequent among participants with NAFLD included obesity (69% v 15%), hypertension (66% v 48%), diabetes (19% v 8%), and dyslipidaemia (63% v 33%). Mean serum alanine aminotransferase levels were higher (29 U/L; SD, 17 U/L v 24 U/L; SD, 14 U/L) and mean median liver stiffness greater (6.5 kPa; SD, 5.6 kPa v 5.3kPa; SD, 2.0 kPa) in participants with NAFLD. Conclusion: The prevalence of NAFLD among adults in regional Victoria is high. Metabolic risk factors are more common among people with NAFLD, as are elevated markers of liver injury.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [1] PREVALENCE OF HYPOTHYROIDISM IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A POPULATION-BASED STUDY
    Almomani, Ashraf
    Hitawala, Asif
    Alkhayyat, Motasem
    Abou Saleh, Mohannad
    Lindsey, Adrian S.
    Mansoor, Emad
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S842 - S843
  • [2] Prevalence of Hyperthyroidism in Patients With Non-Alcoholic Fatty Liver Disease: A Population-Based Study
    Momani, Ashraf
    Almomani, Ashraf
    Alkhayyat, Motasem
    Abou-Saleh, Mohannad
    Mansoor, Emad
    Lindsey, Adrian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S572 - S572
  • [3] Prevalence of non-alcoholic fatty liver disease: population based study
    Amarapurkar, Deepak
    Kamani, Prafull
    Patel, Nikhil
    Gupte, Parijat
    Kumar, Pravin
    Agal, Subhash
    Baijal, Rajiv
    Lala, Somesh
    Chaudhary, Dinesh
    Deshpande, Anjali
    [J]. ANNALS OF HEPATOLOGY, 2007, 6 (03) : 161 - 163
  • [4] Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
    Onwuzo, Somtochukwu Stephen
    Hitawala, Asif Ali
    Boustany, Antoine
    Kumar, Prabhat
    Almomani, Ashraf
    Onwuzo, Chidera
    Monteiro, Jessy Mascarenhas
    Asaad, Imad
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (02) : 265 - 273
  • [5] Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
    Somtochukwu Stephen Onwuzo
    Asif Ali Hitawala
    Antoine Boustany
    Prabhat Kumar
    Ashraf Almomani
    Chidera Onwuzo
    Jessy Mascarenhas Monteiro
    Imad Asaad
    [J]. World Journal of Hepatology, 2023, (02) : 265 - 273
  • [6] . The Prevalence of Non-Alcoholic Fatty Liver Disease Within The Irish Bariatric Population; A Prospective Study
    Kennedy, C.
    Fearon, N.
    Zaborowski, A.
    Doyle, A.
    Nolan, N.
    Heneghan, H.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 5) : S114 - S115
  • [7] A POPULATION-BASED STUDY OF THE PREVALENCE AND PHENOTYPIC CHARACTERISTICS OF WESTERN AUSTRALIAN ADOLESCENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Ayonrinde, Oyekoya T.
    Adams, Leon A.
    Beilin, Lawrie J.
    Mori, Trevor A.
    Shipman, Peter
    Mountain, Jenny A.
    Oddy, Wendy H.
    de Klerk, Nicholas
    Olynyk, John K.
    [J]. HEPATOLOGY, 2008, 48 (04) : 820A - 821A
  • [8] High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study
    Rivera-Andrade, A.
    Kroker-Lobos, M. F.
    Lazo, M.
    Freedman, N. D.
    Smith, J. W.
    Torres, O.
    McGlynn, K. A.
    Groopman, J. D.
    Guallar, E.
    Ramirez-Zea, M.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2019, 29 (02) : 191 - 200
  • [9] The association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
    Rotundo, Laura
    Persaud, Alana
    Feurdean, Mirela
    Ahlawat, Sushit
    Kim, Hyun-seok
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2018, 24 (04) : 392 - 401
  • [10] THE ASSOCIATION OF LEPTIN WITH SEVERITY OF NON-ALCOHOLIC FATTY LIVER DISEASE: A POPULATION-BASED STUDY
    Kim, Hyunseok
    Rotundo, Laura
    Feurdean, Mirela
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1204 - S1204